von Tobias Borgers | Jan. 20, 2021 | Continuous Manufacturing
How a growing digital toolbox is enabling pharmaceutical developers to advance high potent API production. Authors: Niklaus Künzle, Head, Process Technology & Innovation & Conrad Roten, Group Leader, API Development Services Lonza AG Visp, Switzerland. Highly...
von Tobias Borgers | Jan. 17, 2021 | Continuous Manufacturing
Flexibility is crucial in biopharmaceutical manufacturing, because companies increasingly have multiple modalities (e.g., monoclonal antibodies, cell therapies, and gene therapies) in their pipelines. New biopharma facilities often use single-use technology, and...
von Tobias Borgers | Jan. 6, 2021 | Continuous Manufacturing
Santos (Hovione): CM is a tremendous opportunity to advance drugs to the market at a much faster pace than traditional batch manufacturing, and additionally enabling enhanced product quality based on enhanced process understanding and a richer data...
von Tobias Borgers | Dez. 27, 2020 | Continuous Manufacturing
In an industry that tends to lag behind others on matters of technology transformation, today’s market pressures are creating an increasingly imperative need for change in pharmaceutical manufacturing practices. The pharmaceutical industry is heavily regulated, and...
von Tobias Borgers | Dez. 8, 2020 | Continuous Manufacturing
NEW YORK, June 5, 2020 /PRNewswire/ — The Global Pharmaceutical Continuous Manufacturing Market is expected to grow from USD 382.50 Million in 2018 to USD 789.18 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 10.90%. Read the full report:...
von Tobias Borgers | Nov. 30, 2020 | Continuous Manufacturing
Global Continuous Manufacturing Market: Snapshot The global continuous manufacturing market is anticipated to gain impetus due to the development of the pharmaceutical industry. Other important factors that could enhance the growth of the market could be quicker...
